Left ventricular mass in normotensive subjects with autosomal dominant polycystic kidney disease

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British medical journal

• Publication date

  1994-12-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.309.6969.1617PMID 7819937PMCID PMC2541967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.

  1993cited by this paper
• Effect of stress management on blood pressure in mild primary hypertension.

  1993cited by this paper
• The spectrum of cardiovascular abnormalities in autosomal dominant polycystic kidney disease: a 10-year follow-up in a five-generation kindred.

  1992cited by this paper
• Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

  1983cited by this paper
• Determinants of left ventricular hypertrophy and function in hypertensive patients. An echocardiographic study.

  1983cited by this paper

• Cardiac complications in autosomal dominant polycystic kidney disease: links to genotype and CKD severity

  2025cites this paper
• The Relationship of Renalase with Diurnal Blood Pressure Rhythm, Left Ventricular Mass Index and Carotid Intima-media Thickness in Autosomal Dominant Polycystic Kidney Disease.

  2025cites this paper
• Cardiovascular Manifestations and Management in ADPKD

  2023cites this paper
• Subclinical Target Organ Damage in a Sample of Children with Autosomal Dominant Polycystic Kidney Disease: A Pilot Study

  2023cites this paper
• Echocardiographic Abnormalities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients

  2022cites this paper
• Cardiac Involvement in Autosomal Dominant Polycystic Kidney Disease

  2021cites this paper
• Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno-cardiac syndrome.

  2021cites this paper
• Cardiac structural and functional findings in Persian cats with autosomal dominant polycystic kidney disease

  2020cites this paper
• Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress

  2017cites this paper
• Cardiovascular Phenotype in Patients with Autosomal Dominant Polycystic Kidney Disease : Current State , Screening and Prevention

  2016influential citation
• Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways

  2014cites this paper
• The Polymorphism of the ACE Gene Affects Left Ventricular Hypertrophy and Causes Disturbances in Left Ventricular Systolic/Diastolic Function in Patients with Autosomal Dominant Polycystic Kidney Disease

  2014cites this paper
• Cardiovascular abnormalities in patients with autosomal dominant polycystic kidney disease

  2014cites this paper
• Neutrophil-to-lymphocyte ratio, insulin resistance, and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease

  2013cites this paper
• Hypertension artérielle et polykystose rénale autosomique dominante

  2012cites this paper
• Insulin resistance and coronary flow velocity reserve in patients with autosomal dominant polycystic kidney disease

  2012cites this paper
• Improvement of Coronary Flow Velocity Reserve with Telmisartan in Patients with Autosomal-Dominant Polycystic Kidney Disease

  2010cites this paper
• Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease

  2009cites this paper
• Echocardiographic findings in kidney transplant patients with autosomal dominant polycystic kidney disease

  2009cites this paper
• Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries.

  2008cites this paper
• Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.

  2008cites this paper
• Ambulatory Blood Pressure and Endothelial Dysfunction in Patients with Autosomal Dominant Polycystic Kidney Disease

  2007cites this paper
• Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.

  2007cites this paper
• Diastolic Function in Several Stages of Chronic Kidney Disease in Patients with Autosomal Dominant Polycystic Kidney Disease: A Tissue Doppler Imaging Study

  2007cites this paper
• Improvement of Endothelial Dysfunction with Simvastatin in Patients with Autosomal Dominant Polycystic Kidney Disease

  2007cites this paper
• Review: Autosomal Dominant Polycystic Kidney Disease: Role of the Renin-Angiotensin System in Raised Blood Pressure in Progression of Renal and Cardiovascular Disease

  2006cites this paper
• Cardiovascular manifestations of autosomal dominant polycystic kidney disease in young adults.

  2006cites this paper
• Tissue Doppler imaging in the evaluation of left ventricular function in young adults with autosomal dominant polycystic kidney disease.

  2006cites this paper
• Biventricular diastolic dysfunction in patients with autosomal-dominant polycystic kidney disease.

  2005cites this paper
• Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: a prehypertensive state.

  2004cites this paper
• Insulin resistance is related to left ventricular hypertrophy in patients with polycystic kidney disease type 1.

  2003cites this paper
• Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.

  2001cites this paper
• Cardiac involvement in autosomal-dominant polycystic kidney disease: a hypertensive heart disease.

  2001cites this paper
• ACTIGRAPHIC SLEEP-WAKE PATTERNS AND URINARY 6-SULFATOXYMELATONIN EXCRETION IN PATIENTS WITH ALZHEIMER'S DISEASE

  2001cites this paper
• Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease.

  2001cites this paper
• Left Ventricular Hypertrophy in Hypertensive Patients with Autosomal Dominant Polycystic Kidney Disease: Influence of Blood Pressure and Humoral and Neurohormonal Factors

  2000cites this paper
• Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.

  2000cites this paper
• The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models.

  2000cites this paper
• Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.

  1999influential citation
• Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease.

  1999cites this paper
• Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.

  1998cites this paper
• Increased Left Ventricular Mass in Normotensive Type 1 Diabetic Patients With Diabetic Nephropathy

  1998cites this paper
• Extrarenal manifestations of ADPKD.

  1997cites this paper
• The pathogenesis of hypertension in autosomal dominant polycystic kidney disease

  1997cites this paper
• Left Ventricular Hypertrophy in Non‐insulin‐dependent Diabetic Patients With and Without Diabetic Nephropathy

  1997cites this paper
• Ambulatory blood pressure in hypertensive patients with autosomal dominant polycystic kidney disease.

  1997cites this paper
• Néphropathies héréditaires

  1997cites this paper
• Insulin resistance in adult polycystic kidney disease.

  1997cites this paper
• Extrarenal manifestations of ADPKD

  1997cites this paper
• Recent advances in the clinical management of autosomal-dominant polycystic kidney disease.

  1996cites this paper
• Newly diagnosed polycystic kidney disease: what to do with the family?

  1995cites this paper
• Recent advances in the clinical management of autosomal-dominant polycystic kidney disease

  year unknowncites this paper